Individualized Open Lung Ventilation and Postoperative Pulmonary Complications in Thoracic Surgery

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorAerospace Center Hospital

About this trial

This prospective, single-center, randomized controlled trial aims to evaluate the efficacy of an intraoperative "Individualized Open Lung Ventilation" strategy compared to a standard lung-protective ventilation strategy in patients undergoing thoracic surgery.

One-lung ventilation (OLV) is essential for thoracic surgery but can cause lung injury. While standard care often uses fixed ventilation parameters, this study investigates whether personalizing Positive End-Expiratory Pressure (PEEP) to achieve the lowest driving pressure can reduce the incidence of postoperative pulmonary complications (PPCs) within 7 days after surgery.

Eligibility criteria

Qualifiers

Age 18 to 75 years.

American Society of Anesthesiologists (ASA) physical status I-III.

Body mass index between 18 and 30 kg/m².

Scheduled for elective video-assisted thoracoscopic surgery (VATS).

Disqualifiers

Pregnancy or breastfeeding.

Emergency surgery or reoperation.

History of severe pulmonary disease, including chronic obstructive pulmonary disease, pulmonary fibrosis, severe emphysema, pulmonary bullae, pneumothorax, or uncontrolled asthma.

History of heart failure or coronary artery disease.

Trial design

Treatments tested in this trial

  • Standard Lung-Protective Ventilation
  • Individualized Open Lung Ventilation

Treatment groups

352 Participants
are divided into 2 treatment groups

Sponsors and collaborators